Clinical Trial Update: A Study of the Effectiveness and Safety of Risperidone as add-on Therapy to Mood Stabilizers in the Treatment of Manic Episodes Associated With Bipolar Disorder [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating risperidone added to mood stabilizers for manic episodes in bipolar disorder completed, assessing effectiveness and safety.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder
• Manic Episode

Drugs mentioned

• RISPERIDONE (RISPERIDONE)

Snippet

Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Conditions: Bipolar Disorders, Manic Disorder | Phase 3 | Status: COMPLETED